ReviewBrain and behavior2025
MCP-1 Is Elevated in the Cerebral Fluid of Children With Tourette Syndrome: Case Series and Literature Review.
Review in Brain and behavior, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Immune dysregulation in pediatric tic disorders: mechanisms, biomarkers, and therapeutic frontiers.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeThis study aims to investigate cerebrospinal fluid (CSF) in patients with Tourette syndrome (TS) to identify the role of neuroinflammation in the pathophysiology of TS.
methodsWe retrospectively reported cerebrospinal fluid (CSF) examination in four male adolescents diagnosed with severe TS, as indicated by a high Yale Global Tic Severity Scale (YGTSS) score. The examination included routine and biochemical tests, oligoclonal band testing, and analysis of 14 neural autoantibodies. Furthermore, the levels of 34 cytokines were also measured.
findingsCSF examinations revealed that routine and biochemical tests were normal and that no oligoclonal bands were detected. The 14 neural autoantibodies tested were negative. Among the 34 cytokines analyzed, only monocyte chemoattractant protein-1 (MCP-1) levels were significantly elevated.
conclusionsThis study is the first to report elevated levels of MCP-1 in the CSF of patients with TS. Our findings suggest that MCP-1-associated neuroinflammation may play a crucial role in the pathogenesis of TS, indicating that targeting MCP-1 could be a promising therapeutic approach to managing symptoms of TS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.